EEF1AKMT3 and glioma: By analyzing the association between METTL21B expression and clinical features including age, gender, race and WHO grade, we found that WHO grade III glioma has higher expression level of METTL21B compared with WHO grade II (Figure 2), which indicates that METTL21B could be related to malignant behaviors of LGG.